We identify Rap1A as a novel regulator of LPA-induced breast cancer chemotaxis and invasion, and show that LPA stimulates Rap1 activity in breast cancer cells downstream of β-arrestin2, but fails to activate Rap1 in non-malignant mammary epithelial cells. This evidence concerns the gene RAP1A and breast carcinoma.